Wed.Feb 12, 2020

article thumbnail

The Native Antigen Company Introduces Novel Coronavirus Antigens

Drug Discovery Today

Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development